Antibiotic resistance patterns and SDS-PAGE protein profiles of Burkholderia cepacia complex isolates from nosocomial and environmental sources in Venezuela

Medical Science Monitor

Volumn 14, Issue 2, 2008, Pages

  Araque Calderón, Yasmina ^a   Miranda Contreras, Leticia ^b   Rodríguez Lemoine, Vidal ^c   Palacios Prü, Ernesto ^b  

^a Universidad de Oriente   (Venezuela)

^b UNIVERSIDAD DE LOS ANDES   (Venezuela)

^c UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Antibiotic resistance; Burkholderia cepacia complex; Environmental isolates; Nosocomial isolates; SDS PAGE

Indexed keywords

AGAR; AMIKACIN; AZTREONAM; CEFTAZIDIME; COTRIMOXAZOLE; IMIPENEM; MEMBRANE PROTEIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; COMPARATIVE STUDY; CONTROLLED STUDY; DILUTION; DISK DIFFUSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYLOGENETIC TREE; POLYACRYLAMIDE GEL ELECTROPHORESIS; VENEZUELA;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENVIRONMENTAL MICROBIOLOGY; FEMALE; HUMANS; MALE; VENEZUELA;

EID: 39349112714     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Brisse S, Verduin C, Milatovic D et al: Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping. J Clin Microbiol, 2000; 38: 1876-84
2. Coenye T, Vandamme P, Govan J, Lipuma J: Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol, 2001; 39: 3427-36
3. Coenye T, Vandamme P: Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ Microbiol, 2003; 5: 710-29
4. Mahenthiralingam E, Urban TA, Goldberg JB: The multifarious, multireplicon Burkholderia cepacia complex. Nature Rev Microbiol, 2005; 3: 144-56
5. Cain C, Henry A, Waldo R III, Casida L Jr, Falkinham JO III: Identification and characteristics of a novel Burkholderia strain with broad-spectrum antimicrobial activity. Appl Environ Microbiol, 2000; 66: 4139-41
6. Estrada de Los Santos P, Bustillos-Cristales R, Caballero-Mellado J: Burkholderia, a genus rich in plant-associated nitrogen fixers with wide environmental and geographic distribution. Appl Environ Microbiol, 2001; 67: 2790-98
7. Yu W, Wang D, Lin C, Tsou M: Endemic Burkholderia cepacia bacteraemia: clinical features and antimicrobial susceptibilities of isolates. Scand J Infect Dis, 1999; 31: 293-98
8. Di Cello F, Bevivino A, Chiarini L et al: Biodiversity of a Burkholderia cepacia population isolate from the maize rhizosphere at different plant growth stages. Appl Environ Microbiol, 1997; 63: 4485-93
9. Jayaswal R, Fernandez, M, Upadhyay R et al: Antagonism of Pseudomonas cepacia against phytopathogenic fungi. Curr Microbiol, 1993; 26: 17-22
10. Govan J, Hughes J, Vandamme P: Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol, 1996; 45: 395-407
11. Holmes A, Govan J, Goldstein R: Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis, 1998; 4: 221-27
12. Vandamme P, Holmes B, Vancanneyt M et al: Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. Int J Syst Bacteriol, 1997; 47: 1188-200
13. Butler S, Doherty C, Hughes J et al: Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J Clin Microbiol, 1995; 33: 1001-4
14. Daubaras D, Danganan C, Hubner A et al: Biodegradation of 2,4,5-trichlorophenoxyacetic acid by Burkholderia cepacia strain AC1100: evolutionary insight. Gene, 1996; 179: 1-8
15. Parke J, Guriam-Sherman D: Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains Ann Rev Phytopathol, 2001; 39: 225-58
16. Bevivino A, Dalmastri S, Tababacchioni L et al: Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovars status and distribution of traits related to virulence and transmissibility. J Clin Microbiol, 2002; 40: 846-51
17. Meinikow A, Zaborina O, Dhiman N et al: Clinical and environmental isolates of Burkholderia cepacia exhibit differential cytotoxicity towards macrophages and mast cells. Mol Microbiol, 2000; 36: 1481-93
18. Aaron S, Ferris W, Henry D et al: Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med, 2000; 161: 1206-12
19. Rajyaguru J, Muszynski M: Association of resistance to trimethoprim/sulphamethoxazole, chloramphenicol and quinolones with changes in major outer membrane proteins and lipopolysaccharide in Burkholderia cepacia. J Antimicrob Chemother, 1997; 40: 803-9
20. Feizabadi M, Etemadi G, Yadegarinia D et al: Antibiotic resistance patterns and frequency of extended-spectrum b-lactamase-producing isolates of Klebsiella pneumoniae in Tehran. Med Sci Monit, 2006; 12(11): BR362-65
21. Pitt T, Kaufmann M, Patel P et al: Type characterization and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol, 1996; 44: 203-10
22. Araque Y, Vitelli-Flores J, Rodríguez-Lemoine V: Identificación de aislados de Burkholderia spp. y Stenotrophomonas maltophilia por métodos convencionales y el sistema ATB plus. In: Libro de resúmenes XXVII Jornadas Venezolanas de Microbiología "Dr. José Vicente Scorza"; 2001 Nov 4-6; Trujillo, Trujillo, Venezuela
23. Whitby, P, Carter, K, Hatter, K et al: T. Identification of members of the Burkholderia cepacia complex by species-specific PCR. J Clin Microbiol, 2000; 38: 2962-65
24. Clinical and Laboratory Standards Institute/CLSI: Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document, M100-S16: 2006; 184
25. Wu W, Welsh M, Kaufman P, Zhang H: Analysis of gene expression at the protein level. In Methods in Gene Biotechnology. New York, CRC Press, 1997; 241-58
26. Stoscheck CM: Quantitation of protein. In Deutscher MP (ed.). Methods in Enzymology. New York: Academic Press, 1990; 182: 50-68
27. Zhang L, Li X, Poole K: Multiple antibiotic resistance in Stenotrophomonas maltophilia: Involvement of a multidrug efflux system. Antimicrob Agents Chemother, 2000; 44: 287-93
28. Goldman D, Sedman S, Ebert M: Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins. Science, 1981; 211: 1437-38
29. Dice LR: Measures of the amount of ecologic association between species. Ecology, 1945; 26: 297-302
30. Malik A, Hasani S, Shahid M et al: Nosocomial Klebsiella infection in neonates in a tertiary care hospital: Protein profile by SDS-PAGE and klebocin typing as epidemiological markers. Indian J Med Microbiol, 2003; 21: 82-86
31. Parr TR, Moore RA, Moore LV, Hancock REW: Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. Antimicrob Agents Chemother, 1987; 31: 121-23
32. Salazar de Vegas E, Nieves B, Ruiz M et al: Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in Acinetobacter baumannii isolated in Merida, Venezuela. Med Sci Monit, 2007;13(4): BR89-94
33. Smalley J, Charalabous P, Birss A, Hart A: Detection of heme-binding proteins in epidemic strains of Burkholderia cepacia. Clin Diagnost Lab Immunol, 2001; 8: 509-14
34. Aronoff SC: Outer membrane permeability in Pseudomonas cepacia: Dim porin content in a β-Lactam-resistant mutant and in resistant cystic fibrosis isolates. Antimicrob Agents Chemother, 1988; 32: 1636-39
35. Sajjan US, Forstner JF: Role of a 22-kilodalton pilin protein in binding of Pseudomonas cepacia to buccal epithelial cells. Infect Immun, 1993; 61: 3157-63
36. Sajjan U, Wu Y, Kent G, Forstner J: Preferential adherence of cable-piliated Burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. J Med Microbiol, 2000; 49: 875-85